The Opioid Crisis and Its Consequences

Transplantation

Volumn 101, Issue 4, 2017, Pages 678-681

  Weiner, Scott G ^a   Malek, Sayeed K ^a   Price, Christin N ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARFENTANIL; DIAMORPHINE; FENTANYL; OPIATE;

ARTICLE; DISEASE TRANSMISSION; DRUG OVERDOSE; HUMAN; INFECTION RISK; ORGAN TRANSPLANTATION; PAIN; PRESCRIPTION; RISK BENEFIT ANALYSIS; DONOR; DONOR SELECTION; OPIATE ADDICTION; PROCEDURES; SUPPLY AND DISTRIBUTION; TRENDS; UNITED STATES;

DONOR SELECTION; DRUG OVERDOSE; HUMANS; OPIOID-RELATED DISORDERS; TISSUE DONORS; UNITED STATES;

EID: 85016995162     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000001671     Document Type: Article

References (39)

1. Centers for Disease Control and Prevention (CDC). CDC grand rounds: prescription drug overdoses-A U.S. epidemic. MMWR Morb Mortal Wkly Rep. 2012;61:10-3
2. Rudd RA, Aleshire N, Zibbell JE, et al. Increases in drug and opioid overdose deaths-United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2016;64:1378-82
3. Ingrahan C. Heroin deaths surpass gun homicides for the first time, CDC data shows Washington Post; December 8, 2016. https://www. washingtonpost.com/news/wonk/wp/2016/12/08/heroin-deathssurpass-gun-homicides-for-The-first-time-cdc-data-show/?utm-term=. 78d08a9f6b74. Accessed January 1, 2017
4. CDC. Wide-ranging online data for epidemiologic research (WONDER). Atlanta, GA: CDC, National Center for Health Statistics; 2016. http://wonder. cdc.gov. Published 2016 Accessed January 1, 2017
5. National Center for Health Statistics. Mortality in the United States, 2015. https://www.cdc.gov/nchs/products/databriefs/db267.html. Published 2015. Accessed January 1, 2017
6. Kaiser Family Foundation. Kaiser Health Tracking Poll: November 2015. http://kff.org/health-reform/poll-finding/kaiser-health-tracking-poll-november-2015/. Published 2015. Accessed January 1, 2017
7. Centers for Disease Control and Prevention. Drug Poisoning Mortality: United States, 1999-2014. https://blogs.cdc.gov/nchs-data-visualization/ drug-poisoning-mortality/. Accessed January 1, 2017
8. Wright ER, Kooreman HE, Greene MS, et al. The iatrogenic epidemic of prescription drug abuse: county-level determinants of opioid availability and abuse. Drug Alcohol Depend. 2014;138:209-15
9. Frenk SM, Porter KS, Paulozzi LJ. Prescription opioid analgesic use among adults: United States, 1999-2012. In: NCHSData Brief. Hyattsville, MD: National Center for Health Statistics; 2015:1-8
10. Okie S. A flood of opioids, a rising tide of deaths.NEngl JMed. 2010;363: 1981-5
11. Chang H, Daubresse M, Kruszewski S, et al. Prevalence and treatment of pain in EDs in the United States, 2000 to 2010. Am J Emerg Med. 2014; 32:421-31
12. Daubresse M, Chang H, Yu Y, et al. Ambulatory diagnosis and treatment of nonmalignant pain in the United States, 2000-2010. Med Care. 2013; 51:870-878
13. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain-United States, 2016. JAMA. 2016;315:1624-45
14. Manasco AT, Griggs C, Leeds R, et al. Characteristics of state prescription drug monitoring programs: a state-by-state survey. Pharmacoepidemiol Drug Saf. 2016;25:847-51
15. The Commonwealth of Massachusetts. An Act relative to substance use, treatment, education and prevention. http://www.massmed.org/advocacy/ key-issues/opioid-abuse/conference-committee-report-an-act-relative-tosubstance-use,-treatment,-education-and-prevention-(pdf)/. Accessed January 1, 2017
16. IMS Institute for Healthcare Informatics. Medicines Use and Spending in the U.S. https://static1.squarespace.com/static/54d50ceee4b05797b34 869cf/t/5711197b45bf21650748e8ad/1460738430435/IMS+Health +2015.pdf. Published April 2016. Accessed January 1, 2017
17. Kertesz SG. Turning the Tide or Riptide? the Changing Opioid Epidemic. Subst Abus. 2016:1-6. [Epub ahead of print]
18. JonesCM, Logan J, GladdenRM, et al. Vital signs: demographic and substance use trends among heroin users-United States, 2002-2013. MMWR Morb Mortal Wkly Rep. 2015;64:719-25
19. Cicero TJ, EllisMS, SurrattHL, et al. The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA Psychiatry. 2014;71:821-6
20. Gladden RM, Martinez P, Seth P. Fentanyl law enforcement submissions and increases in synthetic opioid-involved overdose deaths-27 states, 2013-2014. MMWR Morb Mortal Wkly Rep. 2016;65:837-43
21. Declaration of Montréal. 2010. http://www.iasp-pain.org/DeclarationofMontreal? navItemNumber=582. Accessed January 1, 2017
22. Meghani SH, Byun E, Gallagher RM. Time to take stock: a meta-analysis and systematic review of analgesic treatment disparities for pain in the United States. Pain Med. 2012;13:150-74
23. Anderson KO, Green CR, Payne R. Racial and ethnic disparities in pain: causes and consequences of unequal care. J Pain. 2009;10: 1187-204
24. Cintron A, Morrison RS. Pain and ethnicity in the United States: a systematic review. J Palliat Med. 2006;9:1454-73
25. Hwang U, Belland LK, Handel DA, et al. Is all pain is treated equally? A multicenter evaluation of acute pain care by age. Pain. 2014;155: 2568-74
26. Department of Veterans Affairs. Pain as the fifth vital sign toolkit. https:// www.va.gov/PAINMANAGEMENT/docs/Pain-As-the-5th-Vital-Sign- Toolkit.pdf. Published October 2000. Accessed January 1, 2017
27. U.S. Department of Health &Human Services. HHS announces new actions to combat opioid epidemic. https://www.hhs.gov/about/news/ 2016/07/06/hhs-announces-new-actions-combat-opioid-epidemic.html. Published July 2016. Accessed January 1, 2017
28. Hoffman J, Tavernise S. Vexing Question on Patient Surveys: DidWe Ease Your Pain? New York Times. http://www.nytimes.com/2016/08/05/ health/pain-treatment-hospitals-emergency-rooms-surveys.html?-r=0. Published August 2016. Accessed January 1, 2017
29. Meier B. Pain Killer: A "Wonder" Drug's Trail of Addiction and Death. 1st ed. Emmaus, Pa: Rodale Books; 2003
30. Portenoy RK, Foley KM. Chronic use of opioid analgesics in nonmalignant pain: report of 38 cases. Pain. 1986;25:171-86
31. Van Zee A. The promotion and marketing of oxycontin: commercial triumph, public health tragedy. Am J Public Health. 2009;99:221-7
32. Abouna GM. Organ shortage crisis: problems and possible solutions. Transplant Proc. 2008;40:34-8
33. Seelye KQ. As Drug Deaths Soar, a Silver Lining for Transplant Patients. New York Times, October 6, 2016. http://www.nytimes.com/2016/10/ 06/us/as-drug-deaths-soar-A-silver-lining-for-organ-transplant-patients. html. Accessed January 1, 2017
34. Organ Procurement and Transplantation Network. http://optn.transplant. hrsa.gov/. Accessed January 1, 2017
35. Goldberg DS, Blumberg E, McCauley M, et al. Improving organ utilization to help overcome the tragedies of the opioid epidemic. Am J Transplant. 2016;16:2836-2841
36. Volk M,Wilk A,Wolfe C, et al. The PHS Increased Risk label is associated with non-utilization of hundreds of organs per year [Abstract]. Am J Transplantation. 2016;16(suppl 3)
37. Duan KI, Englesbe MJ, Volk ML. Centers for Disease Control High Risk Donors and kidney utilization. Am J Transplant. 2010;10:416-420
38. Ellingson K, Seem D, Nowicki M, et al. Estimated risk of human immunodeficiency virus and hepatitis C virus infection among potential organ donors from 17 organ procurement organizations in the United States. Am J Transplant. 2011;11:1201-1208
39. U.S. Surgeon General. Turn the Tide. http://turnthetiderx.org/. Accessed January 1, 2017